229 related articles for article (PubMed ID: 25176167)
1. Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression.
Guilloux JP; Bassi S; Ding Y; Walsh C; Turecki G; Tseng G; Cyranowski JM; Sibille E
Neuropsychopharmacology; 2015 Feb; 40(3):701-10. PubMed ID: 25176167
[TBL] [Abstract][Full Text] [Related]
2. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.
Frank E; Cassano GB; Rucci P; Thompson WK; Kraemer HC; Fagiolini A; Maggi L; Kupfer DJ; Shear MK; Houck PR; Calugi S; Grochocinski VJ; Scocco P; Buttenfield J; Forgione RN
Psychol Med; 2011 Jan; 41(1):151-62. PubMed ID: 20380782
[TBL] [Abstract][Full Text] [Related]
3. Targeting remission by 8 weeks: when should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor?
Cooper-Kazaz R; Rigbi A; Lerer B
Compr Psychiatry; 2011; 52(1):9-16. PubMed ID: 21220060
[TBL] [Abstract][Full Text] [Related]
4. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.
Leuchter AF; Cook IA; Marangell LB; Gilmer WS; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; McCracken JT; Fava M; Iosifescu D; Greenwald S
Psychiatry Res; 2009 Sep; 169(2):124-31. PubMed ID: 19712979
[TBL] [Abstract][Full Text] [Related]
6. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
[TBL] [Abstract][Full Text] [Related]
7. Do atypical features affect outcome in depressed outpatients treated with citalopram?
Stewart JW; McGrath PJ; Fava M; Wisniewski SR; Zisook S; Cook I; Nierenberg AA; Trivedi MH; Balasubramani GK; Warden D; Lesser I; John Rush A
Int J Neuropsychopharmacol; 2010 Feb; 13(1):15-30. PubMed ID: 19341509
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Psychopharmacol; 2005 Mar; 19(2):166-72. PubMed ID: 15728438
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
[TBL] [Abstract][Full Text] [Related]
10. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
van Zyl LT; Lespérance F; Frasure-Smith N; Malinin AI; Atar D; Laliberté MA; Serebruany VL
J Thromb Thrombolysis; 2009 Jan; 27(1):48-56. PubMed ID: 18188512
[TBL] [Abstract][Full Text] [Related]
11. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Clin Psychopharmacol; 2003 Dec; 23(6):563-7. PubMed ID: 14624186
[TBL] [Abstract][Full Text] [Related]
12. Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination.
Rucci P; Frank E; Calugi S; Miniati M; Benvenuti A; Wallace M; Fagiolini A; Maggi L; Kupfer DJ; Cassano GB
Depress Anxiety; 2011 Nov; 28(11):955-62. PubMed ID: 21898715
[TBL] [Abstract][Full Text] [Related]
13. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.
Davis LL; Wisniewski SR; Howland RH; Trivedi MH; Husain MM; Fava M; McGrath PJ; Balasubramani GK; Warden D; Rush AJ
Drug Alcohol Depend; 2010 Mar; 107(2-3):161-70. PubMed ID: 19945804
[TBL] [Abstract][Full Text] [Related]
14. Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations.
Troxel WM; Kupfer DJ; Reynolds CF; Frank E; Thase ME; Miewald JM; Buysse DJ
J Clin Psychiatry; 2012 Apr; 73(4):478-85. PubMed ID: 22152403
[TBL] [Abstract][Full Text] [Related]
15. Early symptom change prediction of remission in depression treatment.
Katz MM; Meyers AL; Prakash A; Gaynor PJ; Houston JP
Psychopharmacol Bull; 2009; 42(1):94-107. PubMed ID: 19204654
[TBL] [Abstract][Full Text] [Related]
16. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
Trials; 2011 Jan; 12():4. PubMed ID: 21208417
[TBL] [Abstract][Full Text] [Related]
17. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
18. Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
Braund TA; Palmer DM; Williams LM; Harris AWF
Psychol Med; 2020 Apr; 50(6):1032-1042. PubMed ID: 31023398
[TBL] [Abstract][Full Text] [Related]
19. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
Fava M; Rush AJ; Alpert JE; Balasubramani GK; Wisniewski SR; Carmin CN; Biggs MM; Zisook S; Leuchter A; Howland R; Warden D; Trivedi MH
Am J Psychiatry; 2008 Mar; 165(3):342-51. PubMed ID: 18172020
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison.
Matreja PS; Badyal DK; Khosla P; Deswal RS
Hum Psychopharmacol; 2007 Oct; 22(7):477-82. PubMed ID: 17647298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
